相关实验视频
Updated: Jan 8, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
与损伤相关的分子模式,免疫血栓形成和败血症中的血管内炎症:叙述综合性综述
Toshiaki Iba1,2, Julie Helms3, Hideshi Okada4
1Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
败血症涉及免疫系统的有害过度反应,导致血栓和器官损伤. 新的治疗方法旨在阻止这种有害的血栓炎路径,以改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 败血症被重新定义为一种失调的宿主反应,涉及炎症,凝血和内皮损伤,形成血栓炎症网络.
- 这个称为免疫血栓形成的过程,当过度时会变得致病性,超出简单的炎症反应范围.
研究的目的:
- 审查最近的机械学进展,将损伤相关的分子模式 (DAMPs),内皮功能障碍和血症中的血管内凝血联系起来.
- 探索这些因素如何促进败血症引起的凝血病和传播性血管内凝血 (DIC) 的发展.
主要方法:
- 整合DAMP (例如,HMGB1,基因组,线粒体DNA) 和它们的受体 (TLR,RAGE) 的机制研究.
- 分析内皮功能障碍,抗凝固剂分子的损失和葡萄糖的降解.
- 检查补体激活,蛋白酶激活受体信号传递,血小板-白细胞聚合物和中性粒细胞外细胞陷 (NETs) 在促进血栓形成中的作用.
主要成果:
- 内源性警示素传播白细胞激活,血小板聚合和内皮干扰,导致血管内皮产生血凝作用.
- 微血管血栓,毛细血管泄漏和器官缺血是这种促凝状态的结果.
- 血小板-白细胞聚合物和NETs促进纤维素沉积和DIC.
结论:
- 针对性的干预措施,如重组血栓模块素,抗血栓素,NET中和和内皮保护,旨在恢复血管平衡.
- 多域生物标志物和机器学习可能使得败血症内型的精确分层.
- 打断DAMP信号传递,免疫激活和凝血的轴线为个性化,机制驱动的败血症治疗提供了一个有希望的途径.
更多相关视频
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
相关概念视频
Inflammation
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Intracellular Signaling Affects Focal Adhesions
Some...
Inflammatory Response I: Vascular and Cellular
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Endocarditis II: Clinical Features of Infective Endocarditis